- Home
- PHYS vs PCVX Comparison
PHYS vs PCVX Comparison
Compare PHYS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHYS
- PCVX
- Stock Information
- Founded
- PHYS N/A
- PCVX 2013
- Country
- PHYS
- PCVX United States
- Employees
- PHYS N/A
- PCVX N/A
- Industry
- PHYS
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PHYS
- PCVX Health Care
- Exchange
- PHYS NYSE
- PCVX Nasdaq
- Market Cap
- PHYS 8.9B
- PCVX 9.6B
- IPO Year
- PHYS N/A
- PCVX 2020
- Fundamental
- Price
- PHYS $24.17
- PCVX $32.23
- Analyst Decision
- PHYS
- PCVX Strong Buy
- Analyst Count
- PHYS 0
- PCVX 9
- Target Price
- PHYS N/A
- PCVX $140.88
- AVG Volume (30 Days)
- PHYS N/A
- PCVX 2.0M
- Earning Date
- PHYS N/A
- PCVX 05-07-2025
- Dividend Yield
- PHYS N/A
- PCVX N/A
- EPS Growth
- PHYS N/A
- PCVX N/A
- EPS
- PHYS N/A
- PCVX N/A
- Revenue
- PHYS N/A
- PCVX N/A
- Revenue This Year
- PHYS N/A
- PCVX N/A
- Revenue Next Year
- PHYS N/A
- PCVX N/A
- P/E Ratio
- PHYS N/A
- PCVX N/A
- Revenue Growth
- PHYS N/A
- PCVX N/A
- 52 Week Low
- PHYS N/A
- PCVX $30.12
- 52 Week High
- PHYS N/A
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- PHYS 74.68
- PCVX 13.91
- Support Level
- PHYS $23.29
- PCVX $30.12
- Resistance Level
- PHYS $23.50
- PCVX $76.61
- Average True Range (ATR)
- PHYS 0.17
- PCVX 3.53
- MACD
- PHYS 0.05
- PCVX -3.57
- Stochastic Oscillator
- PHYS 97.71
- PCVX 4.54
About PHYS SPROTT PHYSICAL GOLD TRUST
Sprott Physical Gold Trust is a closed-end mutual fund trust. The company provides a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical gold bullion without the inconvenience associated with direct investment in physical gold bullion. The company invests mainly in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not and will not speculate about short-term changes in gold prices.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.